News from us and our partners

Tags

Topics

0 results

News
16 May, 2019
Sofinnova Partners’ DNA Script Raises $38.5 Million in Series B Financing
News
14 May, 2019
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
News
13 May, 2019
Sofinnova leads 28-7 Therapeutics' $15M Series A extension
News
22 April, 2019
HOOKIPA Pharma Announces Pricing of Initial Public Offering
News
10 April, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
News
5 April, 2019
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
News
14 March, 2019
AFYREN and the SPI industrial projects fund, operated by Bpifrance, announce the creation of an industrial company, AFYREN NEOXY.
News
13 March, 2019
ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
News
5 March, 2019
DNA Script Announces World's First Enzymatic Synthesis of a High-Purity 200-Nucleotide Strand of DNA
News
5 March, 2019
Micropep Technologies establishes its first Board of Directors and appoints Kevin P. Smith as Non-Executive Chairman
News
4 March, 2019
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
News
26 February, 2019
HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing
News
25 February, 2019
Antoine Papiernik, Managing Partner and Chairman at Sofinnova Partners, gives CNBC his predictions for what’s next in biotech
News
18 February, 2019
HOOKIPA Appoints Michael A. Kelly as Independent Director
News
12 February, 2019
AFYREN secures over 60 million euros of financing to move into its industrial development phase
News
31 January, 2019
Inotrem announces an extension of its license agreement for the biomarker soluble TREM-1 to cardiovascular diseases.

Sofinnova Partners’ DNA Script Raises $38.5 Million in Series B Financing

CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing

Sofinnova leads 28-7 Therapeutics' $15M Series A extension

HOOKIPA Pharma Announces Pricing of Initial Public Offering

NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board

SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath

AFYREN and the SPI industrial projects fund, operated by Bpifrance, announce the creation of an industrial company, AFYREN NEOXY.

ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

DNA Script Announces World's First Enzymatic Synthesis of a High-Purity 200-Nucleotide Strand of DNA

Micropep Technologies establishes its first Board of Directors and appoints Kevin P. Smith as Non-Executive Chairman

Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo

HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing

Antoine Papiernik, Managing Partner and Chairman at Sofinnova Partners, gives CNBC his predictions for what’s next in biotech

HOOKIPA Appoints Michael A. Kelly as Independent Director

AFYREN secures over 60 million euros of financing to move into its industrial development phase

Inotrem announces an extension of its license agreement for the biomarker soluble TREM-1 to cardiovascular diseases.